Danish biotech company Egalet appoints new chairman and new CEO
Michael Fiorini (59) is the former CEO of The East Asiatic Company and a senior executive with A.P. Møller Mærsk.
Seppo Mäkinen remains a member of Egalet's board of directors with Regina Hodits, Atlas Venture, Francesco De Rubertis, Index Ventures and Jan-Eric Österlund, QueQuoin Holdings.
In addition, Egalet has employed Peter Nordkild (52) as its new Chief Executive Officer. Peter Nordkild was previously Chief Commercial Officer of the listed Danish biotech company Pharmexa. Before joining Pharmexa, he held a position as Senior Vice President with Ferring Pharmaceuticals..
Peter Nordkild will supersede Jan Quistgaard, a co-founder and co-owner of Egalet, during September. Jan Quistgaard will continue as external advisor to the management of Egalet.
Most read news
Organizations
Other news from the department people
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.